Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boceprevir in Community Practice: Assessing Safety, Efficacy, Compliance and Quality of Life, Impact of an Education Program

NCT01405027 is registered in ClinicalTrials.gov with Chronic Liver Disease Foundation as lead sponsor.

NCT NCT01405027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01405027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boceprevir in Community Practice: Assessing Safety, Efficacy, Compliance and Quality of Life, Impact of an Education Program
Lead sponsor
Chronic Liver Disease Foundation
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
July 31, 2014
Enrollment
197 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, genotype 1